PITTSBURGH, July 20, 2020 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (Nasdaq:KRYS), a fully integrated gene therapy company driven by its proprietary,…
more on globenewswire.com
PITTSBURGH, July 20, 2020 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (Nasdaq:KRYS), a fully integrated gene therapy company driven by its proprietary,…